Laurens de Haan
#70,355
Most Influential Person Now
Dutch economist
Laurens de Haan's AcademicInfluence.com Rankings
Laurens de Haaneconomics Degrees
Economics
#1863
World Rank
#2137
Historical Rank
Econometrics
#43
World Rank
#45
Historical Rank
Download Badge
Economics
Laurens de Haan's Degrees
- PhD Econometrics Erasmus University Rotterdam
Why Is Laurens de Haan Influential?
(Suggest an Edit or Addition)According to Wikipedia, Laurens de Haan is a Dutch economist and Emeritus Professor of Probability and Mathematical Statistics at the Erasmus University Rotterdam, specializing in extreme value theory. Biography Born in Rotterdam, De Haan received his MA in mathematics from the University of Amsterdam in 1966, and his PhD in mathematics in 1970 under supervision of Johannes Runnenburg for the thesis "On regular variation and sample extremes".
Laurens de Haan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Biological Insights From 108 Schizophrenia-Associated Genetic Loci (2014) (6445)
- Extreme value theory : an introduction (2006) (2140)
- Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs (2013) (2011)
- Residual Life Time at Great Age (1974) (1356)
- The psychosis high-risk state: a comprehensive state-of-the-art review. (2013) (1197)
- Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium (2015) (810)
- A moment estimator for the index of an extreme-value distribution (1989) (760)
- Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects (2016) (736)
- On regular variation and its application to the weak convergence of sample extremes (1973) (708)
- The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data (2014) (646)
- Extreme value theory (2006) (601)
- A Spectral Representation for Max-stable Processes (1984) (547)
- Using a Bootstrap Method to Choose the Sample Fraction in Tail Index Estimation (2000) (496)
- Stationary max-stable fields associated to negative definite functions. (2008) (422)
- The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study (2019) (401)
- Limit theory for multivariate sample extremes (1977) (368)
- Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) (361)
- Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium (2018) (343)
- On the Estimation of the Extreme-Value Index and Large Quantile Estimation (1989) (307)
- Generalized regular variation of second order (1996) (296)
- Systematic review of ERP and fMRI studies investigating inhibitory control and error processing in people with substance dependence and behavioural addictions. (2014) (283)
- Extremal behaviour of solutions to a stochastic difference equation with applications to arch processes (1989) (270)
- How to make a Hill Plot (2000) (250)
- Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study (2017) (217)
- Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. (2014) (210)
- Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder (2015) (206)
- On spatial extremes: With application to a rainfall problem (2008) (203)
- Sea and Wind: Multivariate Extremes at Work (1998) (193)
- A new class of semi-parametric estimators of the second order parameter. (2003) (185)
- On the block maxima method in extreme value theory: PWM estimators (2013) (165)
- Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade (2012) (165)
- Effect of &ohgr;-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial (2017) (162)
- Bivariate tail estimation: dependence in asymptotic independence (2004) (161)
- Diffusion tensor imaging in the early phase of schizophrenia: what have we learned? (2010) (159)
- Tail index estimation for heavy‐tailed models: accommodation of bias in weighted log‐excesses (2007) (132)
- On maximum likelihood estimation of the extreme value index (2004) (129)
- Disability in people clinically at high risk of psychosis (2010) (128)
- Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1–12.5 Years (2019) (125)
- Second-Order Regular Variation and Rates of Convergence in Extreme-Value Theory (1996) (124)
- The 5-year course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders. (2013) (123)
- The generalized Pareto process; with a view towards application and simulation (2012) (122)
- Safety First Portfolio Selection, Extreme Value Theory and Long Run Asset Risks (1994) (122)
- Spatial extremes: Models for the stationary case (2006) (122)
- White Matter Fibertracking in First-Episode Schizophrenia, Schizoaffective Patients and Subjects at Ultra-High Risk of Psychosis (2008) (121)
- Nonparametric estimation of the spectral measure of an extreme value distribution (2001) (120)
- Estimation of the Minimum of a Function Using Order Statistics (1980) (120)
- A Simple Asymptotic Estimate for the Index of a Stable Distribution (1980) (118)
- Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. (2003) (118)
- Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. (2003) (117)
- The Relationship Between Clinical and Personal Recovery in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis (2018) (116)
- Early intervention, untreated psychosis and the course of early schizophrenia (1998) (112)
- Estimating the limit distribution of multivariate extremes (1993) (107)
- Genetic correlation between amyotrophic lateral sclerosis and schizophrenia (2017) (107)
- Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness. (2011) (106)
- Adult attachment and psychotic phenomenology in clinical and non-clinical samples: a systematic review. (2014) (106)
- Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. (2002) (106)
- Slow Variation and Characterization of Domains of Attraction (1984) (105)
- Early detection and intervention in schizophrenia (1998) (104)
- Early interventions in risk groups for schizophrenia: what are we waiting for? (2016) (104)
- On convergence toward an extreme value distribution in C[0,1] (2001) (104)
- Social Functioning and the Course of Early-Onset Schizophrenia (2001) (102)
- Whither the attenuated psychosis syndrome? (2012) (97)
- Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration? (2010) (95)
- Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism. (2008) (93)
- Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables. (2014) (92)
- Complement genes contribute sex-biased vulnerability in diverse illnesses (2020) (92)
- Stationary min-stable stochastic processes (1986) (86)
- On asymptotic normality of the hill estimator (1998) (86)
- Schizophrenia spectrum disorders in later life: prevalence and distribution of age at onset and sex in a dutch catchment area. (2012) (85)
- Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years (2021) (84)
- Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. (2016) (84)
- Sample extremes: an elementary introduction (1976) (84)
- De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia (2019) (82)
- Statistics of heteroscedastic extremes (2014) (81)
- Estimation of the marginal expected shortfall: the mean when a related variable is extreme (2012) (81)
- Approximations to the tail empirical distribution function with application to testing extreme value conditions (2006) (80)
- Semi-parametric Estimation of the Second Order Parameter in Statistics of Extremes (2002) (78)
- To cut a short test even shorter: Reliability and validity of a brief assessment of intellectual ability in Schizophrenia—a control-case family study (2013) (76)
- Subjective Experience and Dopamine D2 Receptor Occupancy in Patients Treated with Antipsychotics: Clinical Implications (2004) (74)
- Estimating the probability of a rare event (1999) (74)
- Estimating the spectral measure of an extreme value distribution (1997) (72)
- Second-order regular variation, convolution and the central limit theorem (1997) (72)
- Age of Onset of Cannabis Use is Associated with Age of Onset of High-Risk Symptoms for Psychosis (2010) (70)
- [Development of psychopathology]. (2006) (67)
- Polyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis. (2013) (66)
- Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study (2018) (65)
- Attitudes of patients toward the first psychotic episode and the start of treatment. (2002) (65)
- In vivo (R)-[11C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis (2016) (65)
- Obsessive-Compulsive Symptoms and Positive, Negative, and Depressive Symptoms in Patients with Recent-Onset Schizophrenic Disorders (2005) (64)
- Extreme Value Statistics (1994) (62)
- On the estimation of high quantiles (1993) (61)
- New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. (2015) (58)
- Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale in schizophrenia patients. (2006) (58)
- Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review (2017) (57)
- Limit Distributions for Order Statistics. II (1978) (57)
- Greater male than female variability in regional brain structure across the lifespan (2020) (57)
- Estimating a multidimensional extreme-value distribution (1993) (56)
- Tail and Quantile Estimation for Strongly Mixing Stationary Sequences (1990) (55)
- Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study (2016) (55)
- Reasons for Cannabis Use and Effects of Cannabis Use as Reported by Patients with Psychotic Disorders (2009) (54)
- Mixed moment estimator and location invariant alternatives (2009) (54)
- On R. Von Mises' Condition for the Domain of Attraction of $\exp(-e^{-x})^1$ (1971) (53)
- AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures (2008) (52)
- Modelling Multivariate Extremes (1999) (51)
- Relationship between working‐memory network function and substance use: a 3‐year longitudinal fMRI study in heavy cannabis users and controls (2014) (50)
- Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies—PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice (2019) (50)
- Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies—PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice (2019) (50)
- Social functioning among older community-dwelling patients with schizophrenia: a review. (2010) (50)
- Effect of Olanzapine and Risperidone on Subjective Well-Being and Craving for Cannabis in Patients with Schizophrenia or Related Disorders: A Double-Blind Randomized Controlled Trial (2008) (49)
- The Rate of Growth of Sample Maxima (1972) (49)
- Cannabis Use in Patients with a First Psychotic Episode and Subjects at Ultra High Risk of Psychosis: Impact on Psychotic- and Pre-Psychotic Symptoms (2010) (49)
- Feasibility of mindfulness‐based therapy in patients recovering from a first psychotic episode: a pilot study (2013) (49)
- An Abel-Tauber Theorem for Laplace Transforms (1976) (49)
- Psychotic Experiences and Related Distress: A Cross-national Comparison and Network Analysis Based on 7141 Participants From 13 Countries (2018) (48)
- Domains of attraction and regular variation in IRd (1984) (48)
- Bias correction in extreme value statistics with index around zero (2013) (47)
- The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder (2019) (47)
- Marked Reduction of AKT1 Expression and Deregulation of AKT1-Associated Pathways in Peripheral Blood Mononuclear Cells of Schizophrenia Patients (2012) (47)
- Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years (2021) (47)
- Alexithymia influences brain activation during emotion perception but not regulation. (2015) (46)
- A Genome-wide Association Analysis of a Broad Psychosis Phenotype Identifies Three Loci for Further Investigation (2014) (46)
- Obsessive–Compulsive Symptoms in First Episode Psychosis and in Subjects at Ultra High Risk for Developing Psychosis; Onset and Relationship to Psychotic Symptoms (2011) (46)
- Subjective Well-Being in Schizophrenia as Measured with the Subjective Well-Being Under Neuroleptic Treatment Scale: A Review (2011) (46)
- Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence (2020) (46)
- A form of regular variation and its application to the domain of attraction of the double exponential distribution (1971) (45)
- AN EXTENSION OF KARAMATA'S TAUBERIAN THEOREM AND ITS CONNECTION WITH COMPLEMENTARY CONVEX FUNCTIONS (1979) (45)
- Evidence for Genetic Overlap Between Schizophrenia and Age at First Birth in Women. (2016) (45)
- Approximation by Penultimate Extreme Value Distributions (1998) (45)
- Obsessive-Compulsive Symptoms in a Randomized, Double-Blind Study With Olanzapine or Risperidone in Young Patients With Early Psychosis (2008) (44)
- On the distribution of tail array sums for strongly mixing stationary sequences (1998) (44)
- Obsessive–compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders (2004) (43)
- Adapting extreme value statistics to financial time series: dealing with bias and serial dependence (2016) (43)
- Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study (2016) (43)
- Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study (2019) (42)
- Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity? (2009) (42)
- Embedding a stochastic difference equation into a continuous-time process (1989) (42)
- Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine (2012) (42)
- Derivatives of regularly varying functions in Rd and domains of attraction of stable distributions (1979) (41)
- On regular variation of probability densities (1987) (41)
- Parametric tail copula estimation and model testing (2008) (41)
- Equivalence classes of regularly varying functions (1974) (41)
- Weighted approximations to tail copula processes with application to testing the extreme value condition (2006) (40)
- Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study. (2011) (40)
- Opinions of mothers on the first psychotic episode and the start of treatment of their child (2004) (40)
- Prevalence of Psychotic Disorders in Patients with Obsessive-Compulsive Disorder (2009) (40)
- Driving us mad: the association of Toxoplasma gondii with suicide attempts and traffic accidents – a systematic review and meta-analysis (2019) (40)
- Theory of mind, insecure attachment and paranoia in adolescents with early psychosis and healthy controls (2013) (39)
- Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis. (2021) (39)
- Stable Probability Distributions and their Domains of Attraction (1997) (39)
- WEIGHTED APPROXIMATIONS OF TAIL COPULA PROCESSES WITH APPLICATION TO TESTING THE BIVARIATE EXTREME VALUE CONDITION BY JOHN H. J. EINMAHL, LAURENS (2006) (39)
- Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case–control study (2020) (39)
- DOMINATED VARIATION AND RELATED CONCEPTS AND TAUBERIAN-THEOREMS FOR LAPLACE TRANSFORMS (1985) (38)
- [Prevention and treatment of somatic complications arising from the use of antipsychotics]. (2008) (38)
- NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical course (2018) (38)
- Symptomatology and Neuropsychological Functioning in Cannabis Using Subjects at Ultra-High Risk for Developing Psychosis and Healthy Controls (2010) (38)
- Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia (2014) (37)
- Bias correction in multivariate extremes (2015) (37)
- Estimation of extreme risk regions under multivariate regular variation (2011) (36)
- Influence of nursing staff attitudes and characteristics on the use of coercive measures in acute mental health services—A systematic review (2019) (36)
- Association Between Smoking Behavior and Cognitive Functioning in Patients With Psychosis, Siblings, and Healthy Control Subjects: Results From a Prospective 6-Year Follow-Up Study. (2018) (36)
- Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial (2019) (35)
- Risperidone-induced leucopenia and neutropenia: a case report (2004) (35)
- Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study (2019) (34)
- Subjective Effects of Cannabis Before the First Psychotic Episode (2009) (34)
- Dopaminergic modulation of the human reward system: a placebo-controlled dopamine depletion fMRI study (2011) (34)
- Child Maltreatment and Clinical Outcome in Individuals at Ultra-High Risk for Psychosis in the EU-GEI High Risk Study (2018) (33)
- To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial (2020) (33)
- Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode (2015) (33)
- The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis (2020) (33)
- The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme (2020) (33)
- Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome (2011) (33)
- Integrals and derivatives of regularly varying functions in Rd and domains of attraction of stable distributions II. (1984) (32)
- Large quantile estimation in a multivariate setting (1995) (32)
- A test procedure for detecting super-heavy tails☆ (2009) (32)
- Longitudinal study of hippocampal volumes in heavy cannabis users (2017) (32)
- Efficacy of Acceptance and Commitment Therapy in Daily Life (ACT-DL) in early psychosis: study protocol for a multi-centre randomized controlled trial (2019) (32)
- Evidence That Transition from Health to Psychotic Disorder Can Be Traced to Semi-Ubiquitous Environmental Effects Operating against Background Genetic Risk (2013) (32)
- Suicide risk in placebo vs active treatment in placebo-controlled trials for schizophrenia. (2003) (31)
- Specificity of facial emotion recognition impairments in patients with multi-episode schizophrenia (2015) (31)
- A CHARACTERIZATION OF MULTIDIMENSIONAL EXTREME -VALUE DISTRIBUTIONS (1977) (31)
- A polygenic resilience score moderates the genetic risk for schizophrenia (2019) (31)
- Subjective experiences during dopamine depletion. (2005) (31)
- Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis (2014) (31)
- On tail trend detection: modeling relative risk (2011) (31)
- Targeted Sequencing of 10,198 Samples Confirms Abnormalities in Neuronal Activity and Implicates Voltage-Gated Sodium Channels in Schizophrenia Pathogenesis (2019) (30)
- The Glutamate Hypothesis: A Pathogenic Pathway from which Pharmacological Interventions have Emerged (2014) (30)
- Local limit theorem for sample extremes (1982) (29)
- Dying Too Soon: Excess Mortality in Severe Mental Illness (2019) (29)
- Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis. (2012) (29)
- A NOTE ON SECOND ORDER CONDITIONS IN EXTREME VALUE THEORY: LINKING GENERAL AND HEAVY TAIL CONDITIONS (2007) (28)
- Reduced Context Effects on Retrieval in First-Episode Schizophrenia (2010) (28)
- Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis (2014) (28)
- Dysregulated Lipid Metabolism Precedes Onset of Psychosis (2020) (28)
- Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis (2009) (27)
- Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia. (2015) (27)
- Conjugate $\Pi$-Variation and Process Inversion (1979) (27)
- Childhood adversities and psychotic symptoms: The potential mediating or moderating role of neurocognition and social cognition (2019) (27)
- Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum (2020) (26)
- Smoking, symptoms, and quality of life in patients with psychosis, siblings, and healthy controls: a prospective, longitudinal cohort study. (2019) (26)
- Medication adherence in patients with schizophrenia: a qualitative study of the patient process in motivational interviewing (2018) (26)
- Personality compensates for impaired quality of life and social functioning in patients with psychotic disorders who experienced traumatic events. (2014) (26)
- Estimating the index of a stable distribution (1999) (26)
- Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls. (2016) (25)
- Striatal D2receptor binding in 22q11 deletion syndrome: an [123 I]IBZM SPECT study (2010) (25)
- Complement genes contribute sex-biased vulnerability in diverse disorders (2020) (25)
- Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study (2020) (24)
- The care needs of elderly patients with schizophrenia spectrum disorders. (2012) (24)
- Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis (2019) (23)
- Non-Glutamatergic Clozapine Augmentation Strategies: A Review and Meta-Analysis (2014) (23)
- Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome (2016) (23)
- Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis (2019) (23)
- Exceedance probability of the integral of a stochastic process (2012) (22)
- Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people (2020) (22)
- Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia. (2008) (22)
- Factor Analysis of the Scale of Prodromal Symptoms: Differentiating between Negative and Depression Symptoms (2011) (22)
- Theory of Mind and attachment styles in people with psychotic disorders, their siblings, and controls (2015) (22)
- The Amsterdam Studies of Acute Psychiatry I (ASAP-I); A prospective cohort study of determinants and outcome of coercive versus voluntary treatment interventions in a metropolitan area (2008) (22)
- Estimating extreme bivariate quantile regions (2009) (22)
- Third order extended regular variation (2006) (21)
- Cue-induced striatal activity in frequent cannabis users independently predicts cannabis problem severity three years later (2016) (21)
- Autistic traits in psychotic disorders: prevalence, familial risk, and impact on social functioning (2020) (21)
- The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study (2014) (21)
- On the observation closest to the origin (1981) (20)
- Reduced brain reward response during cooperation in first-degree relatives of patients with psychosis: an fMRI study (2014) (20)
- Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning – Results from the EU-GEI study (2019) (20)
- Developmental Trajectories of Impaired Community Functioning in Schizophrenia. (2016) (20)
- Neural correlates of reward processing in healthy siblings of patients with schizophrenia (2015) (20)
- Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial (2019) (20)
- Quality of Life in Patients With Psychotic Disorders: Impact of Symptoms, Personality, and Attachment (2014) (20)
- On large deviation for extremes (2003) (19)
- Off-label second generation antipsychotics for impulse regulation disorders: a review. (2010) (19)
- Use of Natural Language Processing to identify Obsessive Compulsive Symptoms in patients with schizophrenia, schizoaffective disorder or bipolar disorder (2019) (19)
- Reliability and Reproducibility of Neuromelanin‐Sensitive Imaging of the Substantia Nigra: A Comparison of Three Different Sequences (2020) (19)
- Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis (2017) (18)
- Weak consistency of extreme value estimators in C[0,1] (2003) (18)
- On the estimation of the exceedance probability of a high level (1990) (18)
- Obsessive–compulsive symptoms and overall psychopathology in psychotic disorders: longitudinal assessment of patients and siblings (2016) (18)
- Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val158 Met polymorphism in adults with 22q11 deletion syndrome (2012) (18)
- Schizophrenia in the Netherlands: Continuity of Care with Better Quality of Care for Less Medical Costs (2016) (18)
- The effect of childhood trauma and Five-Factor Model personality traits on exposure to adult life events in patients with psychotic disorders (2016) (18)
- Joint exceedances of the ARCH process (2004) (17)
- Mortality and Its Determinants in Late-Life Schizophrenia: A 5-Year Prospective Study in a Dutch Catchment Area. (2016) (17)
- Weak limits of sample range (1974) (17)
- Nursing Staff Factors Contributing to Seclusion in Acute Mental Health Care – An Explorative Cohort Study (2017) (17)
- Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder (2002) (17)
- Pericardial and bilateral pleural effusion associated with clozapine treatment (2004) (17)
- The Latent Taxonicity of Schizotypy in Biological Siblings of Probands With Schizophrenia (2018) (17)
- Uniform Rates of Convergence to Extreme Value Distributions (1984) (17)
- Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk. (2017) (17)
- Processing of Facial and Nonsocial Information Is Differentially Associated With Severity of Symptoms in Patients With Multiepisode Schizophrenia (2015) (17)
- Estimates of the Rate of Convergence for Max-Stable Processes (1989) (16)
- Feasibility of teaching motivational interviewing to parents of young adults with recent-onset schizophrenia and co-occurring cannabis use. (2014) (16)
- Priorities and satisfaction on the help needed and provided in a first episode of psychosis. A survey in five European Family Associations☆ (2002) (16)
- Rarely Observed Sample Maxima (2001) (16)
- Disturbed Experience of Self: Psychometric Analysis of the Self-Experience Lifetime Frequency Scale (SELF) (2016) (15)
- Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial. (2019) (15)
- Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls. (2013) (15)
- Cortical Thickness Trajectories across the Lifespan: Data from 17,075 healthy individuals aged 3-90 years (2020) (15)
- Treating depressive episodes or symptoms in patients with schizophrenia (2017) (15)
- Rates of Convergence for Bivariate Extremes (1997) (15)
- Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study (2016) (14)
- [Routine Outcome Monitoring for patients with severe mental illness: a consensus document]. (2010) (14)
- Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings (2021) (14)
- Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use. (2019) (14)
- Tail dependence in independence (2001) (14)
- Self-disturbance in schizophrenia: a phenomenological approach to better understand our patients. (2013) (13)
- On bootstrap sample size in extreme value theory (2002) (13)
- Asymptotically Balanced Functions and Stochastic Compactness of Sample Extremes (1984) (13)
- Limit laws for order statistics (1975) (12)
- Subcortical Volume Trajectories across the Lifespan: Data from 18,605 healthy individuals aged 3-90 years (2020) (12)
- Autistic Symptoms and Social Functioning in Psychosis: A Network Approach (2021) (12)
- Obsessive–compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels (2018) (12)
- Risk factors for psychotic relapse after dose reduction or discontinuation of antipsychotics in patients with chronic schizophrenia. A systematic review and meta-analysis. (2020) (12)
- Crisis Intervention and Acute Psychiatry in Amsterdam, 20 Years of Change: a Historical Comparison of Consultations in 1983 and 2004—2005 (2010) (12)
- Predictors of Adverse Events and Medical Errors Among Adult Inpatients of Psychiatric Units of Acute Care General Hospitals. (2018) (12)
- Almost Sure Continuity of Stable Moving Average Processes with Index Less Than One (1988) (12)
- Medicinal cannabis (Bedrolite) substitution therapy in inpatients with a psychotic disorder and a comorbid cannabis use disorder: A case series (2018) (12)
- Cessation of cannabis use by patients with recent-onset schizophrenia and related disorders. (2008) (11)
- Differences in efficacy on substance abuse between risperidone and clozapine supports the importance of differential modulation of dopaminergic neurotransmission. (2009) (11)
- The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings From the Multinational EU-GEI Study. (2021) (11)
- Sex differences in cognitive functioning of patients at-risk for psychosis and healthy controls: Results from the European Gene–Environment Interactions study (2020) (11)
- New Research Strategy for Measuring Pre- and Postnatal Metal Dysregulation in Psychotic Disorders (2017) (11)
- Von mises-type conditions in second order regular variation (1996) (11)
- Stochastic Compactness of Sample Extremes (1979) (11)
- Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis (2020) (11)
- Comfort, self-confidence, safety, and dopamine D2 receptor occupancy by antipsychotics. (2005) (11)
- Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of Psychosis. (2020) (11)
- Preliminary validation of a clinical staging model in schizophrenia and related disorders. (2017) (11)
- A comparison of indices for identifying the number of clusters in hierarchical clustering: A study on cognition in schizophrenia patients (2015) (10)
- Duplications in RB1CC1 are associated with schizophrenia; identification in large European sample sets (2013) (10)
- The Generalized Pareto process; with application (2012) (10)
- Economic evaluation of brief cognitive behavioural therapy for social activation in recent-onset psychosis (2018) (10)
- On Bahadur's representation of sample quantiles (1979) (10)
- Comparing psychotic experiences in low-and-middle-income-countries and high-income-countries with a focus on measurement invariance (2020) (10)
- Replicated Evidence of Absence of Association between Serum S100B and (Risk of) Psychotic Disorder (2013) (10)
- Migration history and risk of psychosis: results from the multinational EU-GEI study (2021) (10)
- Estimating failure probabilities (2011) (10)
- Evidence for a Shared Etiological Mechanism of Psychotic Symptoms and Obsessive-Compulsive Symptoms in Patients with Psychotic Disorders and Their Siblings (2015) (10)
- Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis (2020) (9)
- Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective (2021) (9)
- The incidence of psychotic disorders among migrants and minority ethnic groups in Europe: findings from the multinational EU-GEI study (2020) (9)
- On Sample Quantiles from a Regularly Varying Distribution Function (1974) (9)
- Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis (2021) (9)
- Increased prevalence of ECG suspicious for Brugada Syndrome in recent onset schizophrenia spectrum disorders (2019) (9)
- Cognitive Behavioral Therapy for Social Activation in Recent-Onset Psychosis: Randomized Controlled Trial (2019) (9)
- [Smoking cessation and schizophrenia]. (2017) (9)
- The impact of affective symptoms on personal recovery of patients with severe mental illness (2018) (9)
- Grey matter, an endophenotype for schizophrenia? A voxel-based morphometry study in siblings of patients with schizophrenia. (2015) (9)
- Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis (2019) (9)
- Testing Extreme Value Conditions (2002) (9)
- [Women, schizophrenia and oestrogen; neurobiological hypotheses and hormonetherapy studies]. (2010) (9)
- Metacognitive training in patients recovering from a first psychosis: an experience sampling study testing treatment effects (2017) (8)
- Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis (2020) (8)
- Early Parental Death and Risk of Psychosis in Offspring: A Six-Country Case-Control Study (2019) (8)
- On functions derived from regularly varying functions (1977) (8)
- Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of First Episode Psychosis patients and controls (2019) (8)
- Childhood trauma and coping in patients with psychotic disorders and obsessive-compulsive symptoms and in un-affected siblings. (2019) (8)
- Social Disability at Admission for a First Psychosis Does Not Predict Clinical Outcome at 5-Year Follow-Up (2011) (7)
- Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine (2018) (7)
- The independent and combined influence of schizophrenia polygenic risk score and heavy cannabis use on risk for psychotic disorder: A case-control analysis from the EUGEI study (2019) (7)
- Active Ingredients and Mechanisms of Change in Motivational Interviewing for Medication Adherence. A Mixed Methods Study of Patient-Therapist Interaction in Patients With Schizophrenia (2020) (7)
- Conditions for quantile process approximations (1999) (7)
- Exploring construct validity of clinical staging in schizophrenia spectrum disorders in an acute psychiatric ward. (2018) (7)
- Individualized prediction of three- and six-year outcomes of psychosis in a longitudinal multicenter study: a machine learning approach (2021) (7)
- Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial (2018) (7)
- Asymptotic Distributions of Multivariate Intermediate Order Statistics (1997) (6)
- Double hits in schizophrenia (2018) (6)
- Toxoplasma gondii Infection and Clinical Characteristics of Patients With Schizophrenia: A Systematic Review and Meta-analysis (2020) (6)
- Association between skin autofluorescence of advanced glycation end products and affective disorders in the lifelines cohort study. (2020) (6)
- Meta-analysis of cognitive functioning in patients with psychotic disorders and obsessive–compulsive symptoms (2020) (6)
- Homesick: residential and care patterns in patients with severe mental illness (2016) (6)
- Reduced specialized processing in psychotic disorder: a graph theoretical analysis of cerebral functional connectivity (2016) (6)
- The Personal Antipsychotic Choice Index (2017) (6)
- On the determination of the temporal and spatial evolution of extreme events (2011) (6)
- Stress reactivity as a putative mechanism linking childhood trauma with clinical outcomes in individuals at ultra-high-risk for psychosis: Findings from the EU-GEI High Risk Study (2020) (6)
- Correction: Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome (2011) (6)
- Exploration of symptom dimensions and duration of untreated psychosis within a staging model of schizophrenia spectrum disorders (2020) (6)
- Comments on “Plotting Positions in Extreme Value Analysis” (2007) (6)
- On functions with small differences (1981) (6)
- A comparison of depressive symptom profiles between current major depressive disorder and schizophrenia spectrum disorder. (2021) (6)
- Convergence of heteroscedastic extremes (2015) (6)
- Association of Toxoplasma gondii Seropositivity With Cognitive Function in Healthy People: A Systematic Review and Meta-analysis. (2021) (6)
- Functional Recovery of Individuals With Serious Mental Illnesses: Development and Testing of a New Short Instrument for Routine Outcome Monitoring (2018) (6)
- The relationship between childhood trauma and clinical characteristics in ultra-high risk for psychosis youth (2019) (6)
- [25 years antipsychotics: back to the future?]. (2008) (5)
- Rarely observed sample maxima@@@Rarely observed sample maxima (2000) (5)
- Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium (2022) (5)
- [Functional remission of people with serious mental illness (SMI): psychometric properties of a new ROM-instrument]. (2015) (5)
- O5.1. CLOZAPINE AND LONG-TERM MORTALITY RISK IN PATIENTS WITH SCHIZOPHRENIA: PRELIMINARY RESULTS FROM A META-ANALYSIS (2018) (5)
- Treating prolactinoma and psychosis: medication and cognitive behavioural therapy (2011) (5)
- How Far Can Man Go (2013) (5)
- Early intervention, social functioning and psychotic relapse of patients with recent‐onset schizophrenic disorders (1998) (5)
- Rising co-payments coincide with unwanted effects on continuity of healthcare for patients with schizophrenia in the Netherlands (2019) (5)
- Longitudinal association between motor and obsessive compulsive symptoms in patients with psychosis and their unaffected siblings (2018) (5)
- Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case−control study (2021) (5)
- Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis (2021) (5)
- Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: the EU-GEI study (2021) (5)
- Phenome-wide and genome-wide analyses of quality of life in schizophrenia (2019) (5)
- Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial (2020) (5)
- Estimating exceedance probabilities in higher-dimensional space (1994) (5)
- Multivariate Pareto distributions: properties and examples (2013) (5)
- Elevated homocysteine levels in schizophrenia. (2004) (5)
- Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosis (2021) (5)
- Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis (2021) (4)
- Estimating space-time trend and dependence of heavy rainfall (2017) (4)
- Characterization and prediction of clinical pathways of vulnerability to psychosis through graph signal processing (2020) (4)
- The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study (2021) (4)
- The Community Assessment of Psychic Experiences: Optimal cut‐off scores for detecting individuals with a psychotic disorder (2021) (4)
- Extreme value estimation for discretely sampled continuous processes (2017) (4)
- The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study (2021) (4)
- A STOCHASTIC PROCESS THAT IS AUTOREGRESSIVE IN TWO DIRECTIONS OF TIME. (1986) (4)
- Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis (2022) (4)
- Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI). (2022) (4)
- T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION (2018) (4)
- Thinner cortex is associated with psychosis onset in individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group mega-analysis (2021) (4)
- Early predictors of mental health in mid‐adulthood (2020) (4)
- The association between migrant status and transition in an ultra-high risk for psychosis population (2021) (3)
- Duration of Untreated Psychosis in First-Episode Psychosis is not Associated With Common Genetic Variants for Major Psychiatric Conditions: Results From the Multi-Center EU-GEI Study (2021) (3)
- Tapering antipsychotic medication: practical considerations (2021) (3)
- Adjunctive Memantine in Clozapine-Treated Refractory Schizophrenia: An Open-Label One-Year Extension Study (2017) (3)
- Association between Advanced Glycation End products and brain volumes in recent onset psychosis (2020) (3)
- Efficacy of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Results from the Multi-Center INTERACT Randomized Controlled Trial (2021) (3)
- Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling Study (2021) (3)
- Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study. (2022) (3)
- Adaptive estimators for the endpoint and high quantities of a probability distribution (1999) (3)
- [Adolescence, schizophrenia and drug abuse: interactive vulnerability. A hypothesis]. (2007) (3)
- Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis. (2010) (3)
- Note on a Paper by H. G. Tucker (1970) (3)
- A Unified Criterion for the Domain of Attraction of Extreme-Value Distributions (1995) (3)
- Dopamine D2-receptor affinity of antipsychotics in relation to subjective well-being in patients with a psychotic disorder (2017) (3)
- [Psychotic disorders: the need for staging]. (2012) (3)
- Tilburg University Estimation of the Marginal Expected Shortfall (2012) (3)
- Review: N. H. Bingham, C. M. Goldie and J. L. Teugels, Regular variation (1988) (3)
- Hirds.v3: High Intensity Rainfall Design System – the Method Underpinning the Development of Regional Frequency Analysis of Extreme Rainfalls for New Zealand (2011) (3)
- Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials. (2022) (2)
- Smoking and the risk for bipolar disorder: causal evidence from a bidirectional Mendelian randomization study (2019) (2)
- Estimation of the Probability of a Failure Set (2006) (2)
- Correction: Joint exceedances of the ARCH process (2006) (2)
- Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial (2021) (2)
- A class of distribution functions with less bias in extreme value estimation (2006) (2)
- Asymptotic properties of a correlation coefficient type statistic connected with the general linear model (1978) (2)
- Discontinuity of psychiatric care for patients with schizophrenia, relation to previous psychiatric care and practice variation between providers: a retrospective longitudinal cohort study (2021) (2)
- The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort Study (2021) (2)
- T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY (2018) (2)
- Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (2019) (2)
- Shortening Duration of Treatment Resistance: The Next Step in the Treatment of Schizophrenia (2020) (2)
- Discussion of "copulas: Tales and facts", by Thomas Mikosch (2006) (2)
- From Speech Illusions to Onset of Psychotic Disorder: Applying Network Analysis to an Experimental Measure of Aberrant Experiences (2020) (2)
- Validation and recalibration of OxMIV in predicting violent behaviour in patients with schizophrenia spectrum disorders (2022) (2)
- [Delusional infestation, a therapeutic challenge]. (2014) (2)
- Memantine add-on to clozapine treatment for residual negative symptoms of schizophrenia (2017) (2)
- From Speech Illusions to Onset of Psychotic Disorder: Applying Network Analysis to an Experimental Measure of Aberrant Experiences (2020) (2)
- T246. RISK FACTORS FOR PSYCHOTIC RELAPSE IN CHRONIC SCHIZOPHRENIA AFTER DOSE-REDUCTION OR DISCONTINUATION OF ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2020) (2)
- The number of active bidders in internet auctions (2013) (2)
- Burying Our Heads in the Sand: The Neglected Importance of Reporting Inter-Rater Reliability in Antipsychotic Medication Trials (2020) (2)
- Transdiagnostic Exploration of the Association of Toxoplasma Gondii with Psychiatric Disorders. a Systematic Review and Meta Analysis (2015) (2)
- [Schizophrenia and the 22q11 deletion syndrome]. (2002) (2)
- Association between cognitive phenotype in unaffected siblings and prospective 3- and 6-year clinical outcome in their proband affected by psychosis (2020) (2)
- On Random Indices and Limit Distributions (1974) (2)
- Greater preference for eveningness is associated with negative symptoms in an ultra‐high risk for psychosis sample (2021) (2)
- Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study. (2022) (2)
- [Changes in crisis intervention and emergency psychiatry, Amsterdam emergency consultations in 1983 and 2005]. (2009) (2)
- Impact of smoking Behavior on cognitive functioning in persons at risk for psychosis and healthy controls: A longitudinal study (2021) (2)
- Approximation by Penultimate Stable Laws (1997) (2)
- Medication strategies in first episode psychosis patients: A survey among psychiatrists (2021) (2)
- Qualitative and quantitative aspects of information processing in first psychosis: latent class analyses in patients, at-risk subjects, and controls. (2015) (2)
- Estimating a multidimensional extreme-value distribution (Abstract) (1993) (1)
- Dysregulated lipid metabolism precedes onset of psychosis in people at clinical high risk (2020) (1)
- Rising co-payments and continuity of healthcare for Dutch patients with bipolar disorder: retrospective longitudinal cohort study (2021) (1)
- Long-term treatment of antipsychotics and combined therapy with other psychotropic medications inducing weight gain in patients with non-affective psychotic disorder: Evidence from GROUP, a longitudinal study (2022) (1)
- Stressful experiences affect the course of co-occurring obsessive-compulsive and psychotic symptoms: A focus on within-subject processes (2020) (1)
- Random transformations for Poisson processes and sup-integral processes (1994) (1)
- [Exercise-promoting interventions for encouraging people with schizophrenia to take physical exercise]. (2012) (1)
- Olanzapine vs haloperidol for treatment of schizophrenia. (2004) (1)
- Early Withdrawal in a Double-Blind Randomized Clinical Trial with Olanzapine and Risperidone Performed in Adolescents with First Psychosis (2006) (1)
- Skin autofluorescence of advanced glycation end products and mortality in affective disorders in the lifelines cohort study: A mediation analysis. (2021) (1)
- Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case–Control Study (2022) (1)
- Association between characteristics of nursing teams and patients' aggressive behavior in closed psychiatric wards (2022) (1)
- Extreme and Intermediate Order Statistics (2006) (1)
- Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study (2019) (1)
- Skin autofluorescence of advanced glycation end products and course of affective disorders in the lifelines cohort study, a prospective investigation. (2020) (1)
- Measuring asymptotic convexity (1995) (1)
- Association of cognitive performance with clinical staging in schizophrenia spectrum disorders: a prospective 6-year follow-up study (2021) (1)
- O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL (2018) (1)
- Consistent empirical estimators of multivariate extreme value distributions (1991) (1)
- Some remarks concerning the quotient of sample median and sample range for a sample of size 2n+1 from a normal distribution (1969) (1)
- Influence of nursing staff characteristics on seclusion in acute mental health care-A prospective two-year follow-up study. (2021) (1)
- Prevalence and Correlates of Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder. (2022) (1)
- A Visual Metaphor Describing Neural Dynamics in Schizophrenia (2008) (1)
- F53. DOSE REDUCTION OF HIGH-DOSE FIRST-GENERATION ANTIPSYCHOTICS OR SWITCH TO ZIPRASIDONE IN LONG-STAY PATIENTS WITH SCHIZOPHRENIA: A 1-YEAR DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL (2018) (1)
- Extreme Quantile and Tail Estimation (2006) (1)
- [The incidence of psychotic disorders among migrants in the Netherlands: findings from the multinational EU-GEI study.] (2021) (1)
- F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS (2018) (1)
- Identifying Electroencephalography Biomarkers in Individuals at Clinical High Risk for Psychosis in an International Multi-Site Study (2022) (1)
- First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data (2022) (1)
- A Brownian Bridge Connected with Extreme Values (1988) (1)
- Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial (2020) (1)
- The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis (2022) (1)
- von Mises' cendition for the domain of attraction of exp(-e-x) (2006) (1)
- Estimation of the Extreme Value Index and Testing (2006) (1)
- An old but still burning problem: Inter-rater reliability in clinical trials with antidepressant medication. (2020) (1)
- The association between smoking behaviour, social cognition and social functioning in patients with a non-affective psychotic disorder: A prospective follow-up study (2021) (1)
- S53. DELINEATING SOCIAL COGNITION IN AUTISM AND PSYCHOSIS (2020) (0)
- Machine learning based prediction and the influence of complement – Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial (2022) (0)
- Structural MRI Differences between Patients with and without First Rank Symptoms: A Delusion? (2015) (0)
- Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial. (2022) (0)
- Attachment Style and Self-Experience: The Association Between Attachment Style and Self-Reported Altered Self-Experience in Patients With Psychotic Disorders, Unaffected Siblings, and Healthy Controls. (2023) (0)
- P.3.083 Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications (2005) (0)
- [High mortality following psychosis: not only due to suicide]. (2015) (0)
- It might be a wonderful opportunity when patients with a psychotic disorder use cannabis (2022) (0)
- [Personalised medicine for psychosis]. (2018) (0)
- Bootstrapping Extreme Value Estimators (2022) (0)
- M83. AUTISTIC TRAITS AS LINKING PIN TO SOCIAL FUNCTIONING IN PSYCHOSIS: A NETWORK APPROACH (2020) (0)
- Influence of cannabis use on incidence of psychosis in people at clinical high risk. (2023) (0)
- Tilburg University Nonparametric estimation of the spectral measure of an extreme value distribution (2001) (0)
- Adjunctive memantine in clozapine-treated refractory schizophrenia: A one-year extension study (2016) (0)
- Acceleration of neuromelanin-sensitive MRI sequences in the substantia nigra using standard MRI options (2022) (0)
- O11.3. A LONGITUDINAL ANALYSIS OF THE EFFECTS OF NEUROTICISM AND EXTRAVERSION ON SUBJECTIVE WELL-BEING IN PATIENTS WITH SCHIZOPHRENIA (2018) (0)
- Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case–control study (2023) (0)
- Measuring process indicators and adverse events to assess the quality of care for inpatients with psychosis (2019) (0)
- F126. PATHWAYS FROM SPEECH ILLUSIONS TO PSYCHOTIC SYMPTOMS IN SUBJECTS AT ULTRA-HIGH RISK FOR PSYCHOSIS: COMBINING AN EXPERIMENTAL PARADIGM OF ABERRANT EXPERIENCES WITH NETWORK ANALYSIS (2018) (0)
- Preface to the third edition (2020) (0)
- Estimation of the Dependence Structure (2006) (0)
- Personal recovery suits us all: A study in patients with non-affective psychosis, unaffected siblings and healthy controls (2023) (0)
- Applications in probability theory of a special kind of regular variation (1976) (0)
- Early intervention and the course of recent onset schizophrenia (1998) (0)
- The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youth at Ultra-High Risk for Psychosis (2019) (0)
- Limit Distributions and Domains of Attraction (2006) (0)
- Comparable dopamine 2 receptor occupancy. (2002) (0)
- Validation and recalibration of OxMIV in predicting violent behaviour in patients with schizophrenia spectrum disorders (2022) (0)
- Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling Study (Preprint) (2021) (0)
- [Every day questions and knowledge]. (2007) (0)
- The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study. (2023) (0)
- [The optimal level of dopaminergic neurotransmission]. (2005) (0)
- Associations between genetic liabilities to smoking behavior and schizophrenia symptoms in patients with a psychotic disorder, their siblings and healthy controls (2023) (0)
- [Compulsory abstinence: integrated treatment measure of schizophrenia combined with comorbid substance abuse]. (2016) (0)
- Active Ingredients and Mechanisms of Change in Motivational Interviewing for Smoking Cessation in Patients With Coronary Artery Disease: A Mixed Methods Study (2021) (0)
- Olanzapine and haloperidol for residual symptoms. (2005) (0)
- [Recommendations regarding diagnosis and treatment of obsessive-compulsive symptoms in schizophrenia]. (2016) (0)
- The Unhealthy Chicken or the Unhealthy Egg: Quitting Smoking Matters: Response to Hajek et al. (2019) (0)
- Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome (2022) (0)
- [The importance of inter-rater reliability in psychopharmacological trials]. (2021) (0)
- [Investigate the future]. (2010) (0)
- Ethnic discrimination and depressed mood: The role of autonomic regulation. (2021) (0)
- Asymptotic distributions of multivariate intermediate order statistics@@@Asymptotic distributions of multivariate intermediate order statistics (1996) (0)
- [Implementation of a stop-smoking support program for patients and employees in a psychiatric hospital: First results]. (2020) (0)
- EPA-0767 – Plasma Oxytocin and Testosterone Levels in Patients with Psychotic Disorder, Their Unaffected Siblings and Healthy Controls: Results from the EU-GEI Project (2014) (0)
- The Puzzle of Functional Recovery in Schizophrenia-Spectrum Disorders—Replicating a Network Analysis Study (2022) (0)
- SPATIAL EXTREMES: MODELS FOR THE STATIONARY CASE BY LAURENS (2006) (0)
- De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia (2020) (0)
- Acceptance and Commitment Therapy in Daily Life (ACT-DL) in early psychosis: findings on treatment adherence and acceptability from the multi-center INTERACT randomized controlled trial (Preprint) (2021) (0)
- Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (2019) (0)
- Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis (2022) (0)
- Short-term sequences of aggressive behavior in psychiatric inpatients with psychotic disorders using Markov models. (2020) (0)
- Estimation in C[0, 1] (2006) (0)
- Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial (2022) (0)
- Correction to: Efficacy of Acceptance and Commitment Therapy in Daily Life (ACT-DL) in early psychosis: study protocol for a multi-centre randomized controlled trial (2021) (0)
- School performance in secondary education shows no decline before the onset of a first episode of psychosis in schizophrenia (2003) (0)
- de travail du personnel 2019-28 Tail Index Estimation : Quantile-Driven Threshold Selection (2019) (0)
- [Residual neuropsychological, structural and functional brain abnormalities after long-term cannabis use]. (2006) (0)
- Differential trajectories of tobacco smoking in people at ultra-high risk for psychosis: Associations with clinical outcomes (2022) (0)
- T34. THE IMPACT OF ANTIDEPRESSANT USE ON THE TRANSITION TO PSYCHOSIS RATE IN THE NEURAPRO TRIAL (2020) (0)
- [Prevention of psychotic disorders; is the time ripe for intervention?]. (2013) (0)
- The bumpy road to achieve reliability of clinical profile characteristics in psychosis and related disorders (2020) (0)
- Use of multiple Polygenic Risk Scores for distinguishing Schizophrenia-spectrum disorder and Affective psychosis categories; the EUGEI study (2021) (0)
- Impact of adverse childhood experiences on educational achievements in young people at clinical high risk of developing psychosis (2023) (0)
- Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients (2019) (0)
- T21. DEVELOPMENT OF PROTEOMIC PREDICTION MODELS FOR OUTCOMES IN THE CLINICAL HIGH RISK STATE AND PSYCHOTIC EXPERIENCES IN ADOLESCENCE: MACHINE LEARNING ANALYSES IN TWO NESTED CASE-CONTROL STUDIES (2020) (0)
- SECOND ORDER REGULAR VARIATION , CONVOLUTIONAND THE CENTRAL LIMIT (1995) (0)
- Impact of smoking behavior on cognitive functioning in persons at risk for psychosis and healthy controls: A longitudinal study – CORRIGENDUM (2022) (0)
- S175. CLINICAL OUTCOMES IN PEOPLE AT HIGH RISK FOR PSYCHOSIS RELATED TO INTERACTIONS BETWEEN POLYGENIC RISK SCORES AND CHILDHOOD ADVERSITY (2020) (0)
- Memantine add-on to clozapine treatment for residual negative symptoms of schizophrenia (2017) (0)
- [Are appearances deceptive? Evidence-based instead of marketing-based psychiatry]. (2016) (0)
- TAIL DEPENDENCE IN INDEPENDENCE GERRIT DRAISMA HOLGER DREES ANA FERREIRA AND LAURENS DE HAAN (2009) (0)
- Development and validation of predictive model for a diagnosis of first episode psychosis using the multinational EU-GEI case-control study and modern statistical learning methods (2023) (0)
- Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis-findings from the EU-GEI study. (2023) (0)
- The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings (2023) (0)
- Author response: Characterization and prediction of clinical pathways of vulnerability to psychosis through graph signal processing (2021) (0)
- Poisson-Stability as a Unifying Factor for Max-Stability and Sum-Stability. (1985) (0)
- Autistic traits and alcohol use in adolescents within the general population (2022) (0)
- Schizophrenia polygenic risk score and cannabis use modify psychosis expression in first episode psychosis patients and population controls (2019) (0)
- Ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the Dutch Medicines Evaluation Board (2023) (0)
- Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studies (2022) (0)
- Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders. (2022) (0)
- 4th Conference on Extreme Value Analysis: Probabilistic and Statistical Models and their Applications (2005) (0)
- Basic Theory in C[0,1] (2006) (0)
This paper list is powered by the following services:
Other Resources About Laurens de Haan
What Schools Are Affiliated With Laurens de Haan?
Laurens de Haan is affiliated with the following schools:
